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The Human Cytomegalovirus Chemokine Receptor
US28 Mediates Vascular Smooth Muscle
Cell Migration
process is exemplified in animal models. Marek's dis-
ease virus (MDV), a naturally occurring herpesvirus that
infects fowl, was found to induce atherosclerotic lesions
in chickens (Fabricant et al., 1983). Similarly, during solid
organ transplantation, rat CMV (RCMV) accelerated TVS,
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occurs as the result of a neoplastic monoclonal prolifera-
tive event (Benditt et al., 1983). The same mechanism
has also been suggested for SMC accumulation duringSummary
restenosis (Speir et al., 1994). In this model, HCMV is
proposed to accelerate the process through an interac-Human cytomegalovirus (HCMV) infection of smooth
tion of one of the viral immediate early proteins with p53.muscle cells (SMCs) in vivo has been linked to a viral
However, HCMV does not induce cellular proliferation inetiology of vascular disease. In this report, we demon-
infected cells in vitro (Lu and Shenk, 1996). Anotherstrate that HCMV infection of primary arterial SMCs
potential mechanism involves SMC proliferation and mi-results in significant cellular migration. Ablation of the
gration in response to the release of growth factors andchemokine receptor, US28, abrogates SMC migration,
cytokines from macrophages and endothelial cells inwhich is rescued only by expression of the viral homo-
response to vessel injury. For example, HCMV increaseslog and not a cellular G protein±coupled receptor
the expression of platelet-derived growth factor (PDGF)(GPCR). Expression of US28 in the presence of CC
receptor, which may induce both proliferation and mi-chemokines including RANTES or MCP-1 was suffi-
gration of SMCs (Zhou et al., 1999). Alternatively, chemo-
cient to promote SMC migration by both chemokinesis
kines, which are low-molecular weight proteins secreted
and chemotaxis, which was inhibited by protein tyro-
by cells, may promote cellular migration, activation, and
sine kinase inhibitors. US28-mediated SMC migration proliferation through binding of their respective G pro-
provides a molecular basis for the correlative evidence tein±coupled receptors (GPCRs) on target cells (Rollins,
that links HCMV to the acceleration of vascular disease. 1997). The chemokines have been divided into subfami-
lies based on the presence of highly conserved cysteine
Introduction residues at the N termini of the proteins. The two major
chemokine groups are the CC chemokines, which in-
Human cytomegalovirus (HCMV) has been linked to the clude MCP-1, MIP-1a and MIP-1b, and RANTES, and
development of vascular diseases, including atheroscle- the CXC chemokines IL-8 and SDF-1a. Chemokines are
rosis, arterial restenosis following angioplasty, and solid associated with a number of human inflammatory dis-
organ transplant vascular sclerosis (TVS) or chronic re- eases, including atherosclerosis and TVS (reviewed in
jection (Peterson et al., 1980; Melnick et al., 1983, 1998; Terkeltaub et al., 1998). Both the CC and CXC chemo-
Zhou et al., 1996). HCMV antigens and nucleic acids kines have been detected in human and experimentally
have been detected in diseased vessels, and HCMV induced animal model atherosclerotic plaques (Nelken
seropositivity is closely associated with the develop- et al., 1991; Yla-Herttuala et al., 1991). Perhaps the most
ment of carotid and coronary artery disease (McDonald convincing evidence that chemokines play a role in vas-
et al., 1989; Hendrix et al., 1991; Speir et al., 1994; Zhou cular disease is exemplified in Apo E2/2 knockout mice,
et al., 1996). While the association of HCMV with vascu- which exhibit a high incidence of atherosclerosis but a
lar disease is provocative, the most compelling evidence greatly reduced occurrence of disease when crossed
that a herpesvirus infection plays a role in the disease with CCR22/2 knockout mice (Boring et al., 1998). Simi-
larly, MCP-12/2 knockout mice when crossed with LDL
receptor±deficient mice demonstrated a significant re-
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All the members of the b herpesviruses and most of
the g herpesviruses encode chemokine receptor homo-
logs (Chee et al., 1990b; Nicholas et al., 1992; Ahuja and
Murphy, 1993; Gompels et al., 1995; Arvanitakis et al.,
1997). Although Epstein Barr virus (EBV) is the only g
herpesvirus that does not encode a chemokine receptor,
viral infection of cells results in the upregulation of the
cellular GPCR BLR2/EBI1 (Burgstahler et al., 1995). The
g herpesviruses primarily encode homologs to the CXC
chemokine receptors, while the b herpesviruses encode
both CC and CXC GPCRs. The conservation of GPCRs in
the b and g herpesvirus genomes suggests an important
role for these molecules in the biology of the virus. Al-
though the majority of these viral GPCR homologs have
been shown to be functional molecules through in vitro
binding studies, which demonstrate cellular Ca21 flux,
the function of these viral molecules in the context of
viral infection has been difficult to assess because of
the lack of relevant in vivo systems.
HCMV contains four chemokine receptors, which are
encoded in the ORFs UL33, UL78, US27, and US28
(Chee et al., 1990a). US28 is the most characterized of
these HCMV GPCR homologs. This molecule is structur-
ally similar to the human chemokine receptor CCR-1
and binds many of the CC chemokines, including
RANTES and MCP-1 (Neote et al., 1993; Kuhn et al.,
1995). The function of US28 during HCMV infection is
unknown, although a recent study has suggested that
US28 may block inflammatory events during HCMV in-
fection by sequestering intracellular chemokines (Bo-
daghi et al., 1998). In the present report, we examined
the role of HCMV in the induction of SMC migration.
We demonstrate that HCMV infection of SMCs induces
migration that is dependent on US28 expression and
the presence of RANTES or MCP-1. These observations
provide evidence that viruses may induce migration of
Figure 1. HCMV Infection Induces SMC MigrationSMCs toward sites of chemokine production through
(A) Cellular migration assay. Cells plated onto transwells (3.0 mmthe expression of a virally encoded chemokine receptor,
pore size) were infected with HCMV, and the number of migratingwhich provides an important link between HCMV and
cells was determined by microscopy at 48±72 hr post infection.
the development of vascular disease. HCMV infection induced migration of arterial SMCs (PASMC,
CASMC, and AoSMC) and did not promote the migration of venial-
derived SMCs (SphVSMC) or endothelial cells (HUVEC) or fibroblastsResults
(NHDF) (n 5 3; error bars are the standard error of the mean).
(B) Phase and fluorescence microscopy of migrating SMCs for theHCMV Infection of SMCs Induces Cellular Migration
presence of GFP (203) and HCMV gB protein (603) (green). Cells
The accumulation of SMCs in the arterial vessel intima were counterstained for actin using rhodamine-conjugated to phal-
during restenosis, TVS, and atherosclerosis is proposed loidin (red).
to involve migration and/or proliferation of these cells (C) HCMV-induced SMC migration in the presence of foscarnet (0.5
mM), an inhibitor of viral late gene expression (n 5 3).at the inflammatory site. Since HCMV has been shown
to infect SMCs both in vivo and in vitro (Melnick et al.,
1983; Tumilowicz et al., 1985; Lemstrom et al., 1993) chamber after 48±72 hr. As shown in Figure 1A, HCMV
and does not induce cellular proliferation (Lu and Shenk, (wt or GFP recombinant viruses) infection of SMCs dra-
1996), we examined the effect of the virus on SMC mobil- matically increased cellular migration. Approximately
ity. For these studies, primary SMCs were plated on 1%±5% of the total SMCs plated in the upper chamber
transwell filters and infected at a multiplicity of infection migrated to the lower chamber, which is comparable to
(MOI) of 10 with wild-type (wt) HCMV or recombinant the migration of other cell types using a similar assay
HCMV strains of either Towne (Vieira et al., 1998) or system (Kundra et al., 1995). Migrating SMCs were pro-
Toledo (Jarvis et al., 1999), which contain an intergenic ductively infected and remained viable up to 60 days
insertion cassette expressing green fluorescent protein post infection. Migration was not observed with either
(HCMV-GFP). At this MOI, all cells are infected with virus. uninfected or mock-infected SMCs. As a positive control
The use of HCMV-GFP in these experiments allowed us for SMC migration, cells were treated with either PDGF
to follow the migration of infected SMCs. Migration was or fibroblast growth factor (FGF), both of which have
quantified by determining the number of cells that mi- been reported to induce SMC movement. HCMV in-
duced migration 10- to 100-fold more than cells treatedgrated across a 3.0 mm transwell filter into the bottom
Cytomegalovirus-Induced Smooth Muscle Cell Migration
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with these growth factors (data not shown). Examination
of SMCs in the lower chamber indicated that .99% of
the cells demonstrated the presence of GFP (Figure 1B)
as well as the HCMV late glycoproteins gB (Figure 1B).
HCMV-induced SMC migration was inhibited by the
presence of anti-HCMV neutralizing antibody, indicating
that virus infection rather than a growth factor in the
inoculum mediated this process (data not shown).
To determine the cellular specificity of HCMV-induced
SMC migration, SMCs obtained from several different
vessel types, including coronary (CA) and pulmonary
(PA) arteries and the aorta (AO) as well as saphenous
vein (SphV), were infected with virus. HCMV-induced
migration occurred in all arterial SMCs but not venous
SMCs. The greatest number of migrating cells was ob-
served in HCMV-infected CA SMCs followed by PA and
AO SMCs (Figure 1A). In addition, neither normal human
dermal fibroblasts (NHDFs) nor human umbilical vein
endothelial cells (HUVECs) migrated upon HCMV infec-
tion. These results indicate that cellular migration in-
duced by HCMV is specific for SMCs derived from the
arteries.
HCMV G Protein±Coupled Receptor US28 Is Required
for SMC Migration
One potential mechanism of HCMV-induced SMC mi-
gration may involve the HCMV induction of either PDGF
or FGF receptors, which can facilitate cell mobility (Zhou
et al., 1999). To examine this issue, HCMV-infected
SMCs were treated with increasing amounts of neutraliz-
Figure 2. Deletion of the HCMV-Encoded Chemokine Receptor
ing antibody directed against these growth factors. Nei- US28 Abrogates SMC Migration
ther antibody to PDGF nor FGF decreased the ability To determine the contribution of US28 to HCMV-induced SMC mi-
of HCMV to induce SMC migration. However, PDGF- gration, cells were infected with (A) HCMV Toledo, (B) HCMV Towne,
or the correlate recombinant strain lacking the US28 gene (HCMV-induced mobility (in the absence of HCMV infection) was
DUS28) (n 5 3).significantly inhibited by anti-PDGF antibodies (data not
shown).
Since cellular GPCRs have been associated with mi-
from HCMV Towne with the same US28 insertion dele-
gration of inflammatory cells, another possible mecha- tion described for the Toledo strain above, further sup-
nism for HCMV-induced SMC migration may involve a porting the notion that US28 was required for virus-
viral chemokine receptor homolog. HCMV encodes four induced SMC migration (Figure 2B).
potential chemokine receptors (US27, US28, UL33, and To demonstrate that US28 mediated the SMC migra-
UL78) (Chee et al., 1990b; Margulies et al., 1996), but only tion, a recombinant adenovirus expressing the viral
US28 is expressed early after virus infection (Bodaghi et chemokine receptor was generated to complement
al., 1998; Vieira et al., 1998). To determine the potential the migration phenotype of HCMV-DUS28. Replication-
kinetic class of the HCMV GPCR involved in SMC migra- defective (E1A2), recombinant adenoviruses express-
tion, cells were treated with the viral DNA synthesis ing GFP (Ad-GFP), US28 (Ad-US28), US28 with a Flag
inhibitor foscarnet, which distinguishes expression of epitope at the N terminus (Ad-US28N), or the cellular
viral early gene(s) from late gene(s). While this inhibitor b-chemokine receptor CCR5 (Ad-CCR5) were generated
blocked late gene expression in cells (data not shown) by cloning these genes into the pDE1sp1B-tet shuttle
that would include UL33, UL78, and US27, treatment of plasmid under the control of an HCMV minimal promoter
HCMV-infected SMCs with foscarnet did not decrease with a tet-responsive element. The cassette is flanked
cell mobility, suggesting that US28 may be involved in by adenovirus E1A sequences, which promote homolo-
cellular movement (Figure 1C). To test this hypothesis, gous recombination with the E1A-deleted adenovirus
recombinant Toledo HCMV strains lacking US28 (inser- 5 genome. Expression of the various genes under the
tion deletion of US28 with a GFP expression cassette) control of the tet-responsive promoter is induced by
were examined for their ability to induce cellular migra- coinfection with a recombinant adenovirus expressing
tion. Infection of SMCs with the recombinant HCMV the tetracycline transactivator (Ad-Trans) (Gossen and
containing a US28 gene deletion (HCMV-DUS28) re- Bujard, 1992). Infection of SMCs with Ad-US28N and
sulted in .10-fold reduction in cellular migration in com- Ad-Trans resulted in expression of US28 with the correct
parison to HCMV-GFP (Figure 2A). Similar results were size protein as determined by Western blot analysis
(Figure 3A). Immunofluorescence analysis indicated theobtained with a second recombinant virus generated
Cell
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Figure 3. Expression of US28, but not CCR5, Rescues Migration of SMCs Infected with HCMV-DUS28
(A) Western immunoblot analysis of cell lysates from U373 cells infected with Ad-Trans and/or Ad-US28N9Flag with Flag antibodies demonstrat-
ing US28 protein expression.
(B) Cell surface immunofluorescence staining of Ad-Trans and Ad-US28N9Flag or Ad-CCR5-infected SMCs using antibodies directed against
the Flag epitope (panels 1 and 2) or CCR5 (panel 3), respectively (shown in green). Nuclei were stained with propidium iodide (red). Magnification,
603.
(C) To assess the ability of US28 to rescue the SMC migration phenotype, cells were coinfected with HCMV-DUS28 and Ad-Trans plus Ad-
US28, Ad-US28N9Flag, Ad-CCR5, Ad-Empty (no insert), or Ad-EGFP. Wild-type HCMV-Toledo was used as a positive control for inducing
SMC migration (n 5 3).
(D) To determine whether US28 expression is sufficient for SMC migration, cells were mock infected or infected with either HCMV, Ad-Trans
and Ad-Empty, Ad-US28N9Flag, or Ad-CCR5 (n 5 3).
presence of plasma membrane expressed US28 (Figure in the absence of other HCMV proteins was capable of
inducing SMC migration, cells were infected with Ad-3B, panels 1 and 2) and CCR5 (Figure 3B, panel 3) in
SMCs infected with Ad-US28N or Ad-CCR5. US28 but US28. As shown in Figure 3D, expression of US28 alone
resulted in a 4-fold increase in migration of SMCs overnot CCR5 was expressed in a polarized fashion, sug-
gesting that US28 was concentrated at the leading edge control treatment, which was comparable to migration
induced by wt HCMV. Expression of the control chemo-of SMCs. The recombinant adenoviruses expressing
US28 were subsequently examined for their ability to kine receptor Ad-CCR5 failed to induce SMC migration,
which correlated with the inability of this GPCR to rescuecomplement SMC migration in HCMV-DUS28-infected
SMCs. As shown in Figure 3C, SMCs infected with HCMV-DUS28.
HCMV-DUS28 and coinfected with Ad-US28 or Ad- In the above experiments, both HCMV and adenovi-
US28N, but not Ad-CCR5 or Ad-GFP, migrated to similar ruses expressing US28 were capable of inducing SMC
levels as cells infected with wt HCMV. The lack of rescue migration without the addition of exogenous chemo-
of HCMV-DUS28 by the Ad-CCR5 suggests that induc- kines. HCMV has been reported to stimulate production
tion of SMC migration is not a general property of all of RANTES (Michelson et al., 1997); however, the recom-
GPCRs. Therefore, US28 expression can restore the binant adenoviruses did not affect chemokine expres-
ability of HCMV-DUS28 to cause SMC migration. sion (data not shown). These observations suggested
two possibilities. The first possibility was that US28 may
constitutively signal in the absence of chemokines simi-Constitutive Production of MCP-1 and Expression
lar to the KSHV ORF73 chemokine receptor (Arvanitakisof US28 Are Sufficient for SMC Migration
et al., 1997). Alternatively, SMCs may constitutively pro-In experiments described above, adenoviruses express-
duce chemokines that stimulate US28. Therefore, unin-ing US28 were sufficient to complement HCMV-DUS28
induction of SMC migration. To determine whether US28 fected SMCs were examined for their ability to produce
Cytomegalovirus-Induced Smooth Muscle Cell Migration
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Figure 5. US28-Induced SMC Migration Involves Chemotaxis
(A) Graphical representation of SMC chemotaxis assay.
(B) To determine whether US28-induced SMC migration involved
chemotaxis, Ad-GFP-, Ad-CCR5-, or Ad-US28-Flag-infected SMCs
were plated in the center of 60 mm dishes in the presence of 5
mg/ml MCP-1 neutralizing antibodies to inactivate endogenously
expressed chemokine. A transwell that did not contain cells (control;
area A) and a transwell that contained allogeneically activated mac-
rophages (area B) were positioned 20 mm on either side of the
Figure 4. CC Chemokines Are Required for US28-Induced SMC Mi-
SMCs. Chemotaxis was determined as the number of cells migrating
gration
to the macrophage source (area B) and was expressed as percent
(A) To determine whether endogenous CC chemokines were respon- control (US28-expressing SMCs found in area A) (n 5 4).
sible for inducing US28-mediated SMC migration, cells were in-
fected with Ad-US28 in the presence of increasing concentrations
did not increase the number of migrating cells, indicatingof neutralizing antibodies against human-MCP-1 (n 5 3).
that saturating amounts of ligand were present (data(B) To determine whether chemokines other than MCP-1 can induce
SMC migration, Ad-US28-infected cells were exposed to increasing not shown). In contrast, SMC migration was not ob-
amounts of recombinant human-RANTES (0.1, 1, 10, and 50 ng/ served when uninfected cells were exposed to increas-
ml) in the presence of 5 mg/ml MCP-1 neutralizing antibodies to ing amounts of RANTES up to 100 ng/ml, indicating that
inactivate endogenously expressed chemokine (n 5 3).
an endogenously expressed chemokine receptor was
not responsible for cell mobility. The above observations
RANTES and MCP-1. We observed that uninfected indicate that US28 and either RANTES or MCP-1 are
SMCs produced high levels of MCP-1 but not RANTES necessary to promote migration of SMCs.
(data not shown). To determine whether production of The US28-induced migration of SMCs observed above
MCP-1 by SMCs was involved in US28-mediated migra- may be explained by either the random movement of
tion, neutralizing antibodies were added to Ad-US28- cells stimulated by ligand binding (chemokinesis), the
infected cultures. Addition of MCP-1 neutralizing anti- directed movement of cells (chemotaxis), or both mech-
bodies to the SMC cultures resulted in an 80% reduction anisms. Since US28-induced SMC migration occurred
in US28-mediated cellular migration (Figure 4A). These in the absence of exogenously added chemokines,
observations indicate that both HCMV-expressed US28 this observation would suggest that the cell movement
and endogenously expressed SMC MCP-1, but not was due to chemokinesis. To determine whether che-
US28 alone, are necessary for the migration event. motaxis was part of the US28-induced SMC migra-
To determine whether US28-induced SMC migration tion, we exposed the SMCs to a continuous source of
was responsive to more than one chemokine, increasing chemokines utilizing allogeneically stimulated macro-
amounts of RANTES were added to cultures. For these phages, which were suspended in a transwell at a fixed
experiments, MCP-1 neutralizing antibodies were added distance in the same plate (Figure 5A). Neutralizing anti-
to US28-expressing SMC cultures to inhibit the effect of body to MCP-1 was added to the supernatant to nullify
endogenously produced MCP-1. Addition of increasing the effects of this chemokine. To control for SMC
amounts of RANTES to the bottom well resulted in a chemokinesis, a control transwell without cells was sus-
dose-dependent increase in SMC migration (Figure 4B). pended at a point equidistant from the SMCs in compari-
In these experiments, a 6-fold difference was observed son to the macrophage transwell in the same plate. In
between Ad-US28-infected SMCs treated with 50 ng/ this assay, SMC migration was determined by counting
ml of RANTES and untreated SMCs expressing US28. cells in area A (control transwell) versus area B (macro-
phage transwell). As shown in Figure 5B, US28 inducedAddition of 100 ng/ml RANTES to these SMC cultures
Cell
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Discussion
In this study, we demonstrate that HCMV infection of
primary arterial but not venous SMCs results in signifi-
cant cellular migration. While HCMV contains over 200
genes, we show that deletion of US28 alone abrogates
SMC migration. This result was unexpected, especially
since HCMV encodes three other GPCRs. We also ob-
served that expression of US28 using recombinant ade-
novirus vectors caused SMC migration similar to that
observed after HCMV infection. In addition, US28-
induced SMC migration was abrogated by addition of
anti-MCP-1 antibodies. These results indicate that US28
is sufficient to induce SMC migration but only in the
presence of SMC constitutively produced MCP-1. This
report demonstrates that a viral chemokine receptor can
directly promote chemotaxis. This observation suggests
Figure 6. US28-Induced SMC Migration Is Sensitive to PTK Inhibi-
a model in which virally encoded chemokine receptorstors and Not Pertussis Toxin
expressed in infected SMCs, which normally lack these
To determine whether US28-mediated SMC migration is sensitive
GPCRs, induce cellular migration to sites of inflamma-to signaling pathway inhibitors, SMCs infected with Ad-US28 were
tion (Figure 7). Our studies provide a molecular basistreated with varying concentrations of pertussis toxin (1±200 mg/ml),
herbimycin A (0.1±5 mg/ml), genistein (5±100 mg/ml), or wortmannin for the vast amount of correlative evidence linking HCMV
(0.005±0.5 mM) (n 5 3). to the acceleration of vascular disease.
The Function of Viral Chemokine Receptors
Several members of the herpesvirus and poxvirus fami-a 2-fold chemotaxis of SMCs to the source of macro-
lies encode viral chemokines or chemokine receptors
phages compared to migration in the absence of a che-
(Chee et al., 1990a; Nicholas et al., 1992; Ahuja and
mokine source. In contrast, SMCs infected with either
Murphy, 1993; Massung et al., 1993; Ahuja et al., 1994;
Ad-CCR5 or Ad-GFP failed to migrate in the presence or
Telford et al., 1995; Arvanitakis et al., 1997; Boshoff et
absence of the fixed macrophage source. These data
al., 1997; Davis-Poynter et al., 1997; Guo et al., 1997;
indicate that chemotaxis is also involved in US28-
Bais et al., 1998). Although several of these viral chemo-
induced SMC migration.
kines and GPCRs exhibit high-affinity binding and al-
US28 has been shown to bind CC chemokines, re- tered signaling properties in comparison to their cellular
sulting in intracellular Ca21 flux (Gao and Murphy, 1994; homologs (Arvanitakis et al., 1997; Boshoff et al., 1997;
Kuhn et al., 1995). GPCRs are coupled to heterotrimeric Gershengorn et al., 1999), the function of these proteins
G proteins such as Gai or Ga16, which can ultimately during the viral life cycle is unknown. One hypothesized
cause release of Ca21 into the cytoplasm (Billstrom et function of these proteins is to allow virus to evade
al., 1998). Various inhibitors of G proteins have been the immune system. For example, the KHSV-encoded
used to distinguish the signaling pathway induced by vMIP-2 demonstrated high-affinity binding for both CC
the stimulated GPCR (Rollins, 1997). To determine and CXC chemokine receptors and has been shown to
whether G proteins were involved in US28-induced SMC be an efficient inhibitor of monocyte chemotaxis (Kledal
migration, US28-expressing cells were treated with the et al., 1997). Alternatively, poxviruses encode a secreted
Gai/o inhibitor pertussis toxin (PTX). As shown in Figure protein (vCCI) without homology to any known chemo-
6, PTX treatment did not abrogate the ability of SMCs kine receptor that is a potent inhibitor of CC chemokine
to migrate. This result was surprising, since PTX was activity (Lalani et al., 1999). Secretion of these viral pro-
shown to inhibit US28-mediated Ca21 flux in cells (Bills- teins is proposed to block T cell and macrophage tar-
trom et al., 1998). Other G proteins may be involved in geting of infected cells. Another function attributed to
US28 signaling in SMCs, or cell migration may differ from virally encoded GPCR is exemplified by the KHSV IL-8
US28-induced Ca21 flux. Signaling through the protein receptor homolog, ORF73, which stimulates the produc-
tyrosine kinase (PTK) pathway has been shown to be tion of vascular endothelial cell growth factor (VEGF)
involved in cell migration processes (Rodriguez-Frade associated with angiogenesis (Bais et al., 1998; Boshoff,
et al., 1999). To address this issue, the effects of the PTK 1998). Unlike the cellular homolog, this receptor is con-
inhibitors genistein and herbimycin A on SMC migration stitutively active in the cell and is considered to mediate
were measured in migration assays. As shown in Figure neoplastic transformation events through protein kinase
6, treatment of SMCs expressing US28 with either PTK C signaling pathways (Arvanitakis et al., 1997). Finally,
inhibitor resulted in total inhibition of cellular migration. EBV does not encode a GPCR but specifically induces
In contrast, treatment of cells with wortmannin, an inhibi- expression of the cellular chemokine receptor BLR2/
tor of PI3K, did not affect migration of US28-expressing EBI1 in activated lymphocytes (Burgstahler et al., 1995).
SMCs, indicating that not all kinase inhibitors block this This receptor binds members of the CC chemokine fam-
event. These results suggest that US28-induced SMC ily and is hypothesized to be involved in specific lympho-
migration is mediated through a signaling process that cyte trafficking to lymphoid tissue.
The lack of in vivo systems to analyze the function ofinvolves the PTK pathway.
Cytomegalovirus-Induced Smooth Muscle Cell Migration
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Figure 7. A Model for the Role of HCMV-US28 in the SMC Migration that Occurs during Vascular Disease
CC chemokines RANTES and MCP-1 are highly expressed during vascular injury, especially during the development of atherosclerosis,
restenosis, and vasculopathies associated with chronic rejection. Our results suggest that US28 expression during HCMV infection of vascular
SMCs induces the migration of these cells toward sites of vascular injury.
US28 has made analysis of this HCMV GPCR difficult. shown to mediate migration of myeloid and lym-
phoid cells through the activation of Gai (Bacon et al.,Since CC chemokine stimulation of the HCMV US28
1995). Interestingly, CCR5 was unable to rescue HCMV-gene results in intracellular Ca21 flux and activation of
DUS28-induced SMC migration, suggesting that the Gmitogen-activated protein (MAP) kinase pathways (Bill-
protein coupling of the receptor was different fromstrom et al., 1998), a potential function of this GPCR is
US28. While pertussis toxin has been shown to blockactivation of cellular signaling pathways necessary for
CCR5-induced cell migration, US28-induced SMC mi-viral replication. While this hypothesis is plausible, the
gration was not affected by treatment of cells with thisgene is clearly unnecessary for replication in vitro, since
inhibitor. These observations suggest that the Gai pro-deletion of the US28 gene does not display any obvious
teins are not involved in US28-induced SMC migration.phenotype (Vieira et al., 1998). This observation does
However, G protein expression is tissue specific, andnot negate the importance of the gene in vivo, since
like other chemokine receptors, US28 has been showndeletion of a mouse cytomegalovirus (MCMV) CC che-
to bind more than one class of G proteins, which includemokine receptor homolog, M33, results in a debilitated
Ga16 and Gai (Billstrom et al., 1998). Binding of chemo-virus in infected mice (Davis-Poynter et al., 1997). An-
kine receptors to multiple G proteins is common andother function attributed to the US28 gene is that expres-
exemplified by CCR2b, which binds at least threesion of the GPCR acts as a sink to bind chemokines,
classes, including Gai, Ga16, and Gaq (Arai and Charo,which would attract antiviral immune response cells,
1996). Expression of Ga16 has been shown to be limitedanalogous to the Poxvirus vCCI protein. This scenario
to cells of hematopoeitic origin and, therefore, is proba-is based on in vitro studies, which demonstrate deple-
bly not expressed in SMCs. Interestingly, angiotensin IItion of extracellular chemokines in the presence of US28
signaling mediates SMC migration through coupling of(Bodaghi et al., 1998). Interestingly, these authors show
Gaq (reviewed in Inagami, 1999). While US28 may alsothat HCMV UL33, another CC chemokine receptor ho-
utilize Gaq for migration, SMCs express additionalmolog, does not play a role in the sequestration of che-
classes of G proteins that also may contribute to themokines correlating with the lack of receptor activity in
migration process.our studies. The ability of US28 to confer SMC migration
SMC migration was blocked by the PTK inhibitorsin the presence of a CC chemokine provides a previously
herbimycin A and genistein, demonstrating that US28unknown phenotypic function for this gene, which may
mediates SMC migration through a protein tyrosine ki-have significant pathological consequences in vascular
nase (PTK) pathway. Migration is proposed to occurdisease, as discussed below. The question remains as
through activation of the PTK focal adhesion kinaseto why the virus would want SMCs to migrate? The
pp125FAK (Ilic et al., 1995). FAK is located at cellularsimple answer is that HCMV may be utilizing the SMCs
focal adhesions and serves to bridge cellular signalingas a cellular vehicle to disseminate virus, similarly to the
to the cytoskeleton through direct phosphorylation of away that the virus uses macrophages. In essence, the
number of cytoskeleton components, including paxillin,virus infects SMCs, which migrate to sites of inflamma-
a-actin, talin, and vinculin. The importance of FAK intion where infiltrating macrophages acquire virus to dis-
cellular migration was demonstrated by the inability ofseminate HCMV throughout the body.
fibroblasts isolated from FAK2/2 mice to migrate (Ilic et
al., 1995). In addition, overexpression of FAK was shown
Signaling Pathways Involved in SMC Migration to enhance movement of CHO cells (Cary et al., 1996).
Hematopoeitic cellular migration induced by ligation of CCR5 and CCR2 have also been shown to induce cellu-
chemokine receptors is mediated through the Gai class lar migration through the PTK pathway (Bacon et al.,
of heterotrimeric G proteins (Bokoch, 1995). Binding of 1996; Mellado et al., 1998). However, US28 but not CCR5
induced SMC migration, indicating a difference in theRANTES to the chemokine receptor CCR5 has been
Cell
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Cambridge, MA) at 1 3 105 cells per well. Two days after seeding,ability of the receptors to either couple to SMC-specific
cells were infected with HCMV at an MOI of 10 for 4 hr. The insertsG proteins or to activate the PTK pathway. Further stud-
were washed and transferred to fresh 12-well plates. Cells migratingies will be required to determine the specificity of US28
to the lower chamber were enumerated at 48±72 hr post infection
G protein coupling in SMCs. using a Nikon TE300 microscope at magnification 103. Experiments
were performed in triplicate with ten random readings of each well.
SMC Migration in Vascular Disease Average cells per well were determined by multiplying the average
number of cells per 103 field by the number of fields per well. MeanThe migration of SMCs induced by HCMV US28 has
and standard deviation were calculated in triplicate.important implications for several vascular diseases.
For US28 rescue experiments, SMCs were infected with HCMV-Restenosis, TVS, and atherosclerosis are all inflamma-
DUS28 (MOI 10) for 4 hr followed by coinfection of cells with Ad-tory processes, which involve endothelial cell damage
Trans and Ad-US28 or Ad-US28C9Flag at MOI of 1000 for an addi-
and inflammatory cell infiltration, followed by SMC mi- tional 4 hr. Subsequently, the transwells were transferred to fresh
gration and stenosis of the vessel. Although HCMV has 12-well plates. Cellular migration was determined as described
been linked to each of these diseases, these processes above.
For CC chemokine addition experiments during the cell migrationare complicated and certainly involve multiple factors.
assay, the recombinant chemokines RANTES and MCP-1 (0.1±100Clearly, CMV has been shown to accelerate restenosis
ng/ml) or antibodies directed against MCP-1 (1±5 mg/ml) (R&D Sys-and TVS in animal models in which stenosis rapidly oc-
tems, Minneapolis, MN) were added at 24 hr post infection andcurs in the diseased arteries. The accumulation of SMCs
again at 36 hr post infection to the bottom well of the transwell.
in the intima is hypothesized to involve both migration Recombinant FGF or PDGF or antibodies directed against these
and proliferative events. PDGF and other growth factors growth factors (R&D Systems) were added at 4 hr post infection.
are known to induce both SMC migration and prolifera- Cycloheximide (100 mg/ml) or foscarnet (0.5 mM) (Sigma) was
added at 4 hr post infection to determine its effects on HCMV-tion. However, we have observed that PDGF and FGF
induced SMC migration. Genistein (5±100 mg/ml), Wortmanninwere not involved in the HCMV-induced SMC migration,
(0.005±0.5 mM), Herbimycin A (0.1±10 mg/ml), and/or pertussis toxinbut ligands known to bind to US28, namely MCP-1 and
(0.16±16 ng/ml) from Calbiochem (La Jolla, CA) were added at 12RANTES, were able to activate cells. These chemokines
hr post infection and added again at 36 hr post infection to determine
may be produced by either SMCs or by other cells in the US28 signaling pathway.
response to the inflammation process and thus contrib-
ute to the overall accumulation of SMCs in the intima Construction of Recombinant Adenovirus Vectors
of the vessel wall. Interestingly, MCP-1 is not only an Adenovirus vectors were constructed using the methods described
important component of US28-mediated SMC migration by Hitt et al. (1994). HCMV US28 and Flag epitope±tagged US28
gene products were amplified by PCR and cloned into the 59 EcoRIbut also the key chemokine mediating atherosclerotic
and 39 XbaI sites within the plasmid pDE1sp1B-tet. Primers usedevents in Apo E and LDL knockout mice (Boring et al.,
included 59US28-TATAGAATTCAAACGTCATCTCGCCGACGTGG,1998; Gu et al., 1998).
39US28-ATATTCTAGATCATGCTGTGGTACCAGGATAC, andOur studies suggest a novel mechanism for the accu-
59US28Flag-ATATGAATTCATGGACTACAAGGACGACGATGA
mulation of SMCs in vascular lesions, whereby virally CAAGACACCGACGACGACGACCGCGGAAC. The CCR5 gene frag-
encoded chemokine receptors might induce SMC mi- ment was cloned into pDE1sp1B using the restriction enzymes
gration to sites of atherogenesis or stenosis. HCMV is BamHI (blunt-end ligated into the EcoRI site of pDE1sp1B) and XbaI
from the plasmid pCDNA-CCR5 (a generous gift from Dr. Davida likely candidate to be involved in long-term chronic
Kabat, OHSU). The plasmid pDE1sp1B-tet was derived fromdisease processes, since this virus is ubiquitous in the
pDE1sp1B (Microbix Inc. Ottawa, Canada) and contains the tet-population. However, HCMV is not the only virus that
responsive cassette, which includes the tet-responsive enhancerencodes chemokine receptors capable of inducing SMC
sequences, CMV minimal promoter, and SV40 late poly(A) signal.
movement. Other human herpesviruses such as HHV6, Flanking adenovirus E1A sequences promoted homologous recom-
which have comparable prevalence in the population, bination with pJM17. Recombinant adenoviruses were produced by
also encode analogous chemokine receptors and infect cotransfection of 293 cells with the shuttle plasmid containing either
US28, US28N9Flag, CCR5, or eGFP (Clontech, Palo Alto, CA) andsimilar cell types in the vasculature (Gompels et al.,
pJM17 (Microbix) containing an E1A-deleted adenovirus genome.1995). While multiple factors other than HCMV may be
Recombinant adenoviruses were plaque purified, and the bulkinvolved in the development of vascular disease, we
stocks were titered on 293 cells by limiting dilution. For all experi-have identified a mechanism as to how a virally encoded
ments using Ad-vectors, expression was driven by coinfection with
chemokine receptor may contribute to this process. Ad-Trans expressing the ªtet offº transactivator.
Experimental Procedures
Protein Detection
For immunofluorcescence, samples were washed with phosphate-Cells and Virus
buffered saline (PBS) and fixed with 2% paraformaldehyde in PBSPulmonary artery (PASMC), coronary artery, aortic, and saphenous
for 15 min at room temperature (rt). For intracellular staining, thevein smooth muscle cells were from Clonetics (San Diego, CA) and
samples were extensively washed with PBS and permeablized andmaintained in SmGm2 media (Clonetics) with 10% fetal bovine se-
blocked in intracellular staining buffer (ISB: 1 g bovine serum albu-rum (FBS; HyClone, St. Louis, MO). NHDFs (Clonetics) were main-
min, sodium azide, 0.5% Triton-X100, and 500 ml PBS) with 10%tained in DMEM medium supplemented with 10% fetal calf serum.
normal goat serum (NGS) for 20 min at rt. Samples were washed,HUVECs (Clonetics) were maintained in endothelial-SFM with 10%
and the primary antibody (diluted in ISB) was incubated for 2 hr athuman AB serum (Sigma, St. Louis, MO). HCMV strains Toledo and
rt. Anti-HCMV antibodies recognizing the HCMV major immediateTowne were obtained from ATCC (Rockville, MD). HCMV expressing
early proteins and glycoprotein B were used to detect HCMV infec-GFP and HCMV Towne-DUS28 were previously described (Vieira et
tion. Anti-a-SMC actin (Dako A/S, Denmark) or phalloidin was usedal., 1998; Jarvis et al., 1999). The HCMV Toledo-DUS28 was con-
to image effects of HCMV on SMC cytoskeleton. Samples werestructed as previously described (Vieira et al., 1998).
washed with ISB and incubated with fluorescein isothiocyanate
(FITC) or L-rhodamine conjugated secondary anti-mouse or anti-Cell Migration Assay
rabbit antibodies (BioSource International, Camarillo, CA), dilutedFor cell migration assays, cells were added to the upper well of
a transwell (12 mm diameter, 3.0 mm pore size, Costar Corning, in ISB at rt for 1 hr. Samples were washed with ISB, mounted, and
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visualized by fluorescence imaging using a Nikon TE300 fluores- Ahuja, S.K., Gao, J.L., and Murphy, P.M. (1994). Chemokine recep-
tors and molecular mimicry. Immunol. Today 15, 281±287.cence microscope.
For cell surface staining, samples were fixed as above and then Arai, H., and Charo, I.F. (1996). Differential regulation of G-protein-
blocked in surface staining buffer (SSB: PBS with 1% BSA, 0.02% mediated signaling by chemokine receptors. J. Biol. Chem. 271,
NaN3, 1 mM MgCl2, and 1.8 mM CaCl2) containing 20% NGS. The 21814±21819.
M2 anti-Flag antibody (M2; Kodak, Easton, NJ) or anti-CCR5 anti- Arvanitakis, L., Raaka-Geras, E., Varma, A., Gershengorn, M.C., and
body was diluted in SSB, and samples were incubated for 1 hr at Cesarman, E. (1997). Human herpesvirus KSHV encodes a constitu-
rt. Samples were then washed with SSB and then incubated for 1 tively active G-protein-coupled receptor linked to cell proliferation.
hr with FITC-conjugated secondary antibody diluted in SSB, washed Nature 385, 347±349.
again with SSB. Cellular nuclei were stained with propidium iodide
Bacon, K.B., Premack, B.A., Gardner, P., and Schall, T.J. (1995).for 10 min at rt and washed in SSB. Samples were visualized by
Activation of dual T cell signaling pathways by the chemokinefluorescence microscopy as described above.
RANTES. Science 269, 1727±1730.For Western blot analysis, 5 3 105 U373 cells, a neuroglioblastoma
Bacon, K.B., Szabo, M.C., Yssel, H., Bolen, J.B., and Schall, T.J.cell line, were mock infected or infected with an MOI 100 of Ad-
(1996). RANTES induces tyrosine kinase activity of stably complexedTrans and/or Ad-US28N9Flag. At 48 hr post infection, the cells were
p125FAK and ZAP-70 in human T-cells. J. Exp. Med. 184, 873±882.lysed in 23 Laemmli's sample buffer (Laemmli, 1970). Samples were
analyzed by 10% SDS±PAGE, and proteins were transferred to nitro- Bais, C., Santomasso, B., Coso, O., Arvanitakis, L., Raaka, E.G.,
cellulose membranes (Schleicher and Schuell, Keene, NH). The blot Gutkind, J.S., Asch, A.S., Cersarman, E., Gerhengorn, M.C., and
was blocked with 1% milk in TBS-Tween 20 (100 mM Tris-Cl [pH Mesri, E.A. (1998). G-protein-coupled receptor of Kaposi's sarcoma-
7.5], 150 mM NaCl, and 0.1% Tween 20) for 1 hr. The M2 anti-Flag associated herpesvirus is a viral oncogene and angiogenesis activa-
antibody (diluted in 1:1000 in TBS-Tween 20) was used for primary tor. Nature 391, 86±89.
detection of US28-Flag proteins with a secondary anti-mouse conju- Benditt, E., Barrett, T., and McDougall, J. (1983). Viruses in the
gated to horseradish peroxidase (Amersham Pharmacia Biotech, etiology of atherosclerosis. Proc. Natl. Acad. Sci. USA 80, 6386±
Piscataway, NJ). Chemiluminescence and autoradiography were 6389.
used for final detection.
Billstrom, M.A., Johnson, G.L., Avdi, N.J., and Worthen, G.S. (1998).
Intracellular signaling by the chemokine receptor US28 during hu-
Detection of Chemokines man cytomegalovirus infection. J. Virol. 72, 5535±5544.
PASMC were plated in a 6-well plate at 5 3 105 cells per well and
Bodaghi, B., Jones, T.R., Zipeto, D., Vita, C., Sun, L., Laurent, L.,mock infected or infected with HCMV Toledo (MOI 10). Cell-free
Arenzana-Seisdedos, F., Virelizier, J.L., and Michelson, S. (1998).culture supernatants collected every 8 hr were cleared of cellular
Chemokine sequestration by viral chemoreceptors as a novel viraldebris by centrifugation (1000 3 g for 10 min) and analyzed for
escape strategy: withdrawal of chemokines from the environment
RANTES or MCP-1 using chemokine-specific sandwich ELISA (R&D
of cytomegalovirus-infected cells. J. Exp. Med. 188, 855±866.
Systems).
Bokoch, G.M. (1995). Chemoattractant signaling and leukocyte acti-
vation. Blood 86, 1649±1660.Chemotaxis Assay
Boring, L., Gosling, J., Cleary, M., and Charo, I. (1998). DecreasedFor chemotaxis assays, SMCs were plated onto the center of 60
lesion formation in CCR22/2 mice reveals a role for chemokines inmm dishes at 1 3 104 cells/50 ml drop of SMC medium (as seen in
the initiation of atherosclerosis. Nature 394, 894±897.Figure 7A). After 12±24 hr, cells were infected with Ad-Trans and
Boshoff, C. (1998). Coupling herpesviruses to angiogenesis. NatureAd-GFP, Ad-CCR5, or Ad-US28Flag at MOI 1000. After an additional
391, 24±25.24 hr, two transwells (0.4 mm pore size) were suspended 20 mm on
either side of the SMCs in 2 ml SMC medium containing anti-MCP-1 Boshoff, C., Endo, Y., Collins, P.D., Takeuchi, Y., Reeves, J.D.,
neutralizing antibodies (R&D Systems). One transwell did not contain Schweickart, V.L., Siani, M.A., Sasaki, T., Williams, T.J., Gray, P.W.,
cells (control; area A), and the other contained allogeneically acti- Moore, P.S., Chang, Y., and Weiss, R.A. (1997). Angiogenic and HIV-
vated macrophages (area B). Macrophages were produced as de- inhibitory functions of KSHV-encoded chemokines. Science 278,
scribed by SoÈ derberg-Naucler et al. (1997), and migration assays 290±294.
were assembled at 3 days post stimulation of macrophage cultures. Bruning, J.H., Persoons, M.C.J., Lemstrom, K.B., Stals, F.S., De
Migration was determined by counting the SMCs in area A versus Clereq, E., and Bruggeman, C.A. (1994). Enhancement of trans-
area B. Chemotaxis was determined as the number of cells migrating plantation associated atherosclerosis by CMV, which can be pre-
toward the macrophage source (area B) compared to the control vented by antiviral therapy in the form of HPMPC. Transplant Int.
source (area B), and this number was expressed as percent control 7, 365±370.
(US28-expressing SMCs found in area A).
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